2014, Number 07
PDF size: 931.93 Kb.
ABSTRACTBackground: The Essure® contraceptive device consists of a titanium and nickel coiled spring containing Dacron fibers. It is placed under hysteroscopic visualizaron in the proximal section of the Fallopian tube. The microinsert acts by inducing a tissue reaction that permanently blocks the tube within three months.
Objective: Show our experience in the use and insertion of the Essure® device, in a prívate office.
Methods: We reviewed insertion procedure, complications, degree of tolerance and acceptance by user. Between June 2008 and May 2013 fifty cases with Essure® placement were made in our office.
Results: The average age was 36 years, as for the average number of pregnancies was two. The procedure time average was 6 minutes 25 seconds, no intraoperative complication was reported. All patients expressed very good tolerance and high degree of satisfaction with the procedure. A simple abdominal radiography was performed three months after the hysteroscopy to demónstrate the correct placement and position of the device, in all patients.
Conclussion: The number of patients is enough to show the advantages of the method and the possibility of performing it in an ambulatory environment, as it can be a prívate office with the correct equipment to do it.
Valle R, Caringnan C, Wrigth T. The STOP prehysterectomy investigation group. Tissue response to the STOP microcoil trascervical permanent contraceptive device: results from a prehysterectomy study. Fertil Steril 2001;76:974-980.
Rios-Castillo J, Velasco E, Arjona-Berral J. Efficacy of Essure hysteroscopic sterilization-5 years follow up of 1200 women. Gynecol Endocrin 2012;29:580-582.
Thiel A, Carson G. Cost-Effectiveness analiysis Comparing the Essure Tubal Sterilization Procedure and Laparoscopic Tubal Sterilization. JOCG 2008;67:581-585.
Miño M, Arjona J, Pelegrin B, Provedano B, Chacón E. Success rate and patient satisfaction with the Essure sterilization in an outpatient setting: a prospective study of 857 women. BJOG 2007;89:763-766.
Kevin JF, Carigan CS, Cher D. The safety and effectiveness of a new hysteroscopic method for permanent birth control: results of the first Essure clinical study. Aust N Z Obstet Gynecol 2001;41:364.
Úbeda A, Labastida R, Dexeus S. Essure: A new device for hysteroscopic tubal sterilization in an outpatient setting. Fertil Steril 2004;33:221.
Kerin JF, Cooper JM, Price T, Van Herendael B, Cayuela-Font E, Cher D, Carignan CS. Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II study. Hum Reprod 2003;108:1223-1230.
Moses AW, Burgis JT, Bacon JL, Risinger J. Pregnancy after Essure placement: report of two cases. Fertil Steril 2008;89:9-11.
Basinski, C. A Review of Clinical Data for Currently Approved Hysteroscopic Sterilization Procedures. Med Reviews 2010;11:101-110.
Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of ectopic pregnancy after tubal sterilization. U.S. Collaborative Review of Sterilization Working Group. N Engl J Med 1997;336:762-767.
Avendaño B, Cruz M, Rojas P. Anticoncepción por histeroscopia. Una nueva alternativa. An Med 2009;54:215-221.
Duffy S, Marsh F, Rogerson L, Hudson H. Female sterilization: a cohort controlled comparative study of ESSURE versus laparoscopic sterilization. BJOG 2005;112:1522- 1528.